Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Liver MultiScan is an emerging diagnostic tool using multiparametric MRI to quantify liver disease. In a two-centre prospective validation study, 161 consecutive adult patients who had clinically-indicated liver biopsies underwent contemporaneous non-contrast multiparametric MRI at 3.0 tesla (proton density fat fraction (PDFF), T1 and T2* mapping), transient elastography (TE) and Enhanced Liver Fibrosis (ELF) test. Non-invasive liver tests were correlated with gold standard histothological measures. Reproducibility of Liver MultiScan was investigated in 22 healthy volunteers. Iron-corrected T1 (cT1), TE, and ELF demonstrated a positive correlation with hepatic collagen proportionate area (all p < 0·001). TE was superior to ELF and cT1 for predicting fibrosis stage. cT1 maintained good predictive accuracy for diagnosing significant fibrosis in cases with indeterminate ELF, but not for cases with indeterminate TE values. PDFF had high predictive accuracy for individual steatosis grades, with AUROCs ranging from 0.90–0.94. T2* mapping diagnosed iron accumulation with AUROC of 0.79 (95% CI: 0.67–0.92) and negative predictive value of 96%. Liver MultiScan showed excellent test/re-test reliability (coefficients of variation ranging from 1.4% to 2.8% for cT1). Overall failure rates for Liver MultiScan, ELF and TE were 4.3%, 1.9% and 15%, respectively. Liver MultiScan is an emerging point-of-care diagnostic tool that is comparable with the established non-invasive tests for assessment of liver fibrosis, whilst at the same time offering a superior technical success rate and contemporaneous measurement of liver steatosis and iron accumulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
Cohen, J. F., Korevaar, D. A., Altman, D. G., Bruns, D. E., Gatsonis, C. A., Hooft, L., Irwig, L., Levine, D., Reitsma, J. B., de Vet, H. C. W., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012799 · Cited by 2,570
Noureddin, M., Lam, J., Peterson, M. R., Middleton, M., Hamilton, G., Le, T.-A., Bettencourt, R., Changchien, C., Brenner, D. A., Sirlin, C., et al. (2013) · Hepatology · doi:10.1002/hep.26455 · Cited by 550
Pavlides, M., Banerjee, R., Sellwood, J., Kelly, C. J., Robson, M. D., Booth, J. C., Collier, J., Neubauer, S., & Barnes, E. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.009 · Cited by 212
Characterisation of liver fat in the UK Biobank cohort
Wilman, H. R., Kelly, M., Garratt, S., Matthews, P. M., Milanesi, M., Herlihy, A., Gyngell, M., Neubauer, S., Bell, J. D., Banerjee, R., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0172921 · Cited by 159
Self-citationNascimbeni, F., Lebray, P., Fedchuk, L., Oliveira, C. P., Alvares-da-Silva, M. R., Varault, A., Ingiliz, P., Ngo, Y., de Torres, M., Munteanu, M., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.037 · Cited by 82
Research works printed but not linked: 29
- Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 64(1), 73–84 (2016). · DOI · Paper page
- Davies, S.C. Chief Medical Officer Annual Report 2011. Preprint at, https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/141773/CMO_Annual_Report_2011_Chapter_2c.pdf (2011).
- The All-Party Parliamentary Hepatology Group (APPHG) Inquiry into Improving Outcomes in Liver Disease. Liver Disease: Today’s complacency, tomorrow’s catastrophe. Preprint at, http://www.ias.org.uk/uploads/APPHG%20report%20March%202014%20FINAL.pdf (2014).
- Williams, R. et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet. 384(9958), 1953–1997 (2014). · DOI · Paper page
- Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D. C. & Roudot-Thoraval, F. The burden of liver disease in Europe: a review of available epidemiological data. J. Hepatol. 58(3), 593–608 (2013). · DOI · Paper page
- Kan, V. Y. et al. Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia. Can. J Gastroenterol Hepatol. 29(2), 72–76 (2015). · DOI
- Pang, J. X. et al. Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease. PLoS One. 9(4), e95776 (2014). · DOI · Paper page
- Castera, L. et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 51(3), 828–835 (2010). · DOI · Paper page
- Pavlov, C. S. et al. Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease. Cochrane Database Syst Rev. 1, CD010542 (2015).
- Irvine, K. M. et al. The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease. Liver Int. 36(3), 370–377 (2016). · DOI · Paper page
- Poynard, T. et al. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C. J. Hepatol. 59(4), 675–683 (2013). · DOI
- Ahmed, H. U. et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 389(10071), 815–822 (2017). · DOI · Paper page
- Kang, G. H. et al. Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J. Magn Reson Imaging. 34(4), 928–934 (2011). · DOI · Paper page
- Singh, S. et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin. Gastroenterol Hepatol. 13(3), 440–451 (2015). · DOI · Paper page
- Banerjee, R. et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J. Hepatol. 60(1), 69–77 (2014). · DOI · Paper page
- Philips, B. et al. Oxford Centre for Evidence-based Medicine – Levels of Evidence. Preprint at, http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/ (2009).
- Wyatt, J., Hubscher, S. & Bellamy, C. Tissue pathways for liver biopsies for the investigation of medical disease and for focal lesions. Preprint at, https://www.rcpath.org/resourceLibrary/tissue-pathways-liver-biopsies-mar-14.html (2014).
- Calvaruso, V. et al. Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient. Hepatology. 49(4), 1236–1244 (2009). · DOI · Paper page
- Scheuer, P. J., Williams, R. & Muir, A. R. Hepatic pathology in relatives of patients with haemochromatosis. J. Pathol Bacteriol. 84, 53–64 (1962). · DOI · Paper page
- Landis, J. R. & Koch, G. G. The measurement of observer agreement for categorical data. Biometrics. 33(1), 159–174 (1977). · DOI · Paper page
- Viera, A. J. & Garrett, J. M. Understanding interobserver agreement: the kappa statistic. Fam. Med. 37(5), 360–363 (2005).
- Hoad, C. L. et al. A study of T(1) relaxation time as a measure of liver fibrosis and the influence of confounding histological factors. NMR Biomed. 28(6), 706–714 (2015). · DOI · Paper page
- Mozes, F. E., Tunnicliffe, E. M., Pavlides, M. & Robson, M. D. Influence of fat on liver T1 measurements using modified Look-Locker inversion recovery (MOLLI) methods at 3T. J. Magn Reson Imaging. 44(1), 105–111 (2016). · DOI
- National Institute for Health and Care Excellence (NICE). Non-alcoholic fatty liver disease (NAFLD): assessment and management. Preprint at, https://www.nice.org.uk/guidance/ng49 (2016).
- Blake, L., Duarte, R. V. & Cummins, C. Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging. BMJ Open. 6(9), e010507 (2016). · DOI · Paper page
- Byrne, C. D. & Targher, G. Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease. Gastroenterology. 150(1), 7–10 (2016). · DOI
- Eddowes, P. J. et al. Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease. Aliment. Pharmacol Ther. 47(5), 631–644 (2018). · DOI · Paper page
- Hernando, D., Levin, Y. S., Sirlin, C. B. & Reeder, S. B. Quantification of liver iron with MRI: state of the art and remaining challenges. J. Magn Reson Imaging. 40(5), 1003–1021 (2014). · DOI · Paper page
- Sarigianni, M. et al. Accuracy of magnetic resonance imaging in diagnosis of liver iron overload: a systematic review and meta-analysis. Clin. Gastroenterol Hepatol. 13(1), 55–63 e55 (2015). · DOI
Cited by
Andersson, A., Kelly, M., Imajo, K., Nakajima, A., Fallowfield, J. A., Hirschfield, G., Pavlides, M., Sanyal, A. J., Noureddin, M., Banerjee, R., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.09.041 · Cited by 148
Self-citationRepeatability and reproducibility of multiparametric magnetic resonance imaging of the liver
Bachtiar, V., Kelly, M. D., Wilman, H. R., Jacobs, J., Newbould, R., Kelly, C. J., Gyngell, M. L., Groves, K. E., McKay, A., Herlihy, A. H., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0214921 · Cited by 117
Self-citationKendall, T. J., Jimenez-Ramos, M., Turner, F., Ramachandran, P., Minnier, J., McColgan, M. D., Alam, M., Ellis, H., Dunbar, D. R., Kohnen, G., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02602-2 · Cited by 92
Self-citationMeta-analysis: enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases
Hinkson, A., Lally, H., Gibson, H., Jones, R., Rowe, I. A., Shinkins, B., & Parker, R. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17385 · Cited by 51
Authors, & Collaborators: (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1880-2388 · Cited by 30
Metadata
- Authors
- McDonald, N., Eddowes, P. J., Hodson, J., Semple, S. I. K., Davies, N. P., Kelly, C. J., Kin, S., Phillips, M., Herlihy, A. H., Kendall, T. J., Brown, R. M., Neil, D. A. H., Hübscher, S. G., Hirschfield, G. M., & Fallowfield, J. A.
- Venue
- Scientific Reports
- Published
- 2018-06-15
- Volume
- 8
- Issue
- 1
- Pages
- 9189-9189
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2808157877
- Cited by
- 76
- References
- 6
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study. https://app.cochat.ai/papers/10.1038/s41598-018-27560-5
- The paper
- McDonald, N., Eddowes, P. J., Hodson, J., Semple, S. I. K., Davies, N. P., Kelly, C. J., Kin, S., Phillips, M., Herlihy, A. H., Kendall, T. J., Brown, R. M., Neil, D. A. H., Hübscher, S. G., Hirschfield, G. M., & Fallowfield, J. A. (2018). Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study. Scientific Reports. https://doi.org/10.1038/s41598-018-27560-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.